Today’s AI Top Pick: CELH

7/30/2026 · Swing Setup + Squeeze screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Swing Setup + SqueezeCELHBUY NOW8.7 / 107/30/2026

CELH is the cleanest intersection of a passed fundamental screen and a confirming multi-timeframe forecast tape in this pool. Fundamental score is 7.5 (tied for highest), with a very compelling growth/valuation combo: salesYoY 123.34%, epsNextY 23.56%, PEG 0.78, fwdPe 14.61, analyst recom 1.36, and targetUpsidePct 93.9%. Profitability is real (operMargin 19.8%, ROE 13.69%) — unlike most of the healthcare names here that pass on paper but bleed cash. Short float 21.31% adds squeeze fuel. The tape confirms in a way almost no other name in this list does. bullish_prob is 1.0 and near_term_bullish is 0.8 (highest in pool). Forecasts stack up: 1h fc_short +5.11%/mid +5.66%/long +12.3%; 4h mid +42.55%/long +43.33%; 1d short +14.23%/mid +55.55%/long +48.16%; and even the weekly long turns positive at +21.28%. Crucially, you are NOT chasing: position_in_21bar_range is only 29.64% on the daily, drawdown from the 21-bar high is -12.82%, and the stock is down -36.86% YTD — this is coiled, not extended. Compare to IRTC (99% of range, +5% weekly forecast turning to -26% long) or ARQT (98.56% of range with -52% long forecast) — those are the traps. KRMN was the closest challenger (fc_short +45%, fc_long +54%, position 27.6% of range, fundamental score 6.25), but bullish_prob is null and RBC just lowered its target to $85 with 'near-term concerns' called out in headlines. AVAV has bullish_prob 1 but a weekly fc_long of -6.94% breaks the multi-TF alignment. TGTX and DLO carry higher fundamental scores but both show near_term_bullish signals with uniformly negative forecast prints across every timeframe — the screen catches them, the tape rejects them. News check: The CELH-adjacent headlines are all about competitor Vita Coco (COCO) getting an outlook upgrade — mildly negative competitive read-through, but no CELH-specific guidance cut, litigation, dilution, or short report. Weighed against the multi-TF forecast strength and squeeze setup, this is a manageable risk, not a thesis-breaker. TODAY is the entry because we're sitting at the low third of the 21-bar range with forecast models pointing to +48-55% on the mid/long daily horizon — waiting means giving up the entry zone if the near-term +14% short forecast plays out.

Entry zone

$28.40–$29.20 (starter here at $28.91; add on any dip toward $28.00 which is near the 21-bar low)

Stop loss

$26.40 (below the recent 21-bar low; ~8.7% risk, honors the -12.82% drawdown structure)

First target

$33.00–$34.00 (roughly the 1d fc_short +14% projection and pre-drop supply)

Longer target

$42.00–$45.00 (aligned with 1d fc_mid +55% / fc_long +48% and consistent with the 93.9% analyst upside, over 2–4 months)

Risks

Consumer Defensive energy-drink category showing competitive pressure — Vita Coco (COCO) just got outlook raised, and CELH is already -39.12% year-over-year, so market share fears could re-accelerate
Debt/Equity 1.95 is elevated for a consumer staples name and PE 68.94 leaves no room if the growth story wobbles
Short float 21.31% is a double-edged sword: fuels squeeze upside but amplifies any bad-print gap down
Weekly fc_short is -10.33% — the near-term daily setup is bullish but a weekly close below $26 would invalidate the multi-TF alignment
Q2 earnings likely in the next few weeks; the 1d forecast strength may be baking that in and any miss vs. the +23.56% epsNextY expectation resets the whole thesis

Honorable mentions

KRMNSecond-best forecast alignment (1h fc_long +54.08%, 4h fc_mid +60.28%, 1d fc_mid +48.99%) with position only 27.6% of 21-bar range. Fundamental score 6.25, recom 1.46, targetUpside 123.7%. Held back by null bullish_prob, RBC PT cut to $85, and 'near-term concerns' language in headlines.

AVAVbullish_prob 1.0, near_term 0.6, huge daily fc_mid +60.84% / fc_long +69.3%, deeply oversold (-41.25% YTD, position 7.61% of daily range). Positive catalysts this week (Applied Intuition partnership, FLIR order for Titan). Held back by weekly fc_long -6.94% (broken multi-TF alignment) and negative operating margin -1.12%.

Full ranking (22)

#	Symbol	Verdict	Score	Read
1	CELH	BUY NOW	8.7	Full multi-TF alignment (bullish_prob 1, near_term 0.8) with 1d fc_mid +55.55%, position only 29.64% of range, and fundamental score 7.5.
2	KRMN	BUY NOW	7.6	Massive forecast stack (fc_long +54% 1h, +67% 4h) from position 27.6% of range; slight news drag from RBC PT cut to $85.
3	AVAV	BUY PULLBACK	6.9	bullish_prob 1, 1d fc_long +69.3%, deeply washed out, but weekly fc_long -6.94% breaks the ideal alignment.
4	BIRK	BUY PULLBACK	6.0	Best pure fundamentals (score 7.5, fwdPe 14.94, profitMargin 16.26%) but forecast magnitudes are small (fc_long +5.37% 4h, +2.88% 1d).
5	TARS	WAIT	5.4	bullish_prob 1 with 4h fc_long +22.44%, but weekly forecasts collapse to -35.87% and Zacks flags a likely negative Q2 print.
6	SVM	WAIT	5.0	1h fc_long +40.93% and PEG 0.16 look great, but weekly fc_long -57.29% is a giant red flag.
7	IRTC	BUY PULLBACK	4.6	bullish_prob 1 and 4h fc_long +25.69% but sitting at 99.37% of 1h range — do not chase; wait for a pullback.
8	RGEN	WAIT	4.4	Q2 beat and JPM raised PT to $175, but every timeframe's mid/long forecast is negative (-14.96% 1d mid).
9	BCRX	WAIT	4.1	Fundamental score 3.75 and 117% upside per analysts, but 4h fc_long -22.57% and 1d fc_long -9.63% — tape disagrees with analysts.
10	VRDN	WAIT	4.0	bullish_prob 1 and 4h fc_long +27.51%, but 1h at 86.56% of range and profitMargin -482.55%.
11	DLO	WAIT	3.8	Best fundamentals in pool (score 8, roe 37.2%) but every single forecast horizon prints negative — screen passes, tape fails.
12	CHYM	WAIT	3.7	1d fc_short +5.53% is the only bright spot; 1h at 81.5%–86.26% of range and no bullish_prob.
13	TGTX	AVOID	3.2	Fundamental score 8 but bullish_prob 0, near_term 0, and 1d fc_short -41.19% — classic screen trap after 91% weekly run.
14	AXGN	WAIT	3.0	Just raised 2026 outlook (+5.1% pop) but 1wk fc_long -75.01% and 1d fc_mid -43.55% argue the news is priced in.
15	IOVA	AVOID	2.6	Short float 25.75% squeeze potential but 4h fc_long -32.21% and profitMargin -123.92%.
16	RYTM	AVOID	2.5	JPM initiated OW at $145 but 1wk fc_long -45.35% and roe -285.76% — tape says the upgrade is late.
17	HNGE	AVOID	2.0	Sitting at 0% of daily 21-bar range with 1d fc_long -37.18% and Zacks flagging a Q2 earnings decline.
18	CYTK	AVOID	2.0	PS 92.18, operMargin -605%, and 1d fc_long -31.07% — no confirming signal anywhere.
19	ARQT	AVOID	1.7	Stretched at 98.56% of weekly range with 1wk fc_long -52.66% and SeekingAlpha downgrade to Hold.
20	QURE	AVOID	1.6	1wk fc_long -61.25% after +160% run; profitMargin -1350.73%.
21	TWST	AVOID	1.5	+169% YTD but 1d fc_long -48.13% and Simply Wall St flags overvaluation — mean-reversion trap.
22	AGIO	AVOID	1.2	Tebapivat sickle cell setback headline this week and 1h fc_long -28.9% — actively deteriorating.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord